Synthesis and antitumor activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones

被引:0
作者
Andreani, A
Granaiola, M
Leoni, A
Locatelli, A
Morigi, R
Rambaldi, M
Giorgi, G
Salvini, L
Garaliene, V
机构
[1] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy
[2] Univ Siena, Ctr Interdipartimentale Anal & Determinaz Struttu, I-53100 Siena, Italy
[3] Lithuanian Inst Cardiol, LT-3007 Kaunas, Lithuania
来源
ANTI-CANCER DRUG DESIGN | 2001年 / 16卷 / 2-3期
关键词
antitumor activity; cardiotonic activity; cytotoxicity; imidazo-thiazole; indole;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones, analogs of compounds recently published, is described. The E/Z isomerism was studied by means of nuclear Overhauser effect experiments and X-ray crystallography. All the compounds were tested as potential antitumor agents. They were also tested as potential inhibitors of cyclin-dependent kinase 1 (CDK1), in order to determine if the antitumor activity was related to this mechanism of action. The results showed that under certain substitution conditions (5-methoxy group for the indole benzene ring and 2-methyl group for the imidazothiazole system), an interesting antitumor activity was found for some compounds. From the analysis of the antitumor data, 3-[(2,6-dimethylimidazo[2,1-b]-thiazol-5-yl)methylene]-5-methoxy-2-indolinone was the most active of the whole series.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 15 条
[1]   Potential antitumor agents. Part 29: Synthesis and potential coanthracyclinic activity of imidazo[2,1-b]thiazole guanylhydrazones [J].
Andreani, A ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Recanatini, M ;
Garaliene, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (09) :2359-2366
[2]   Synthesis and potential coanthracyclinic activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones [J].
Andreani, A ;
Locatelli, A ;
Leoni, A ;
Rambaldi, M ;
Morigi, R ;
Bossa, R ;
Chiericozzi, M ;
Fraccari, A ;
Galatulas, I .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (11) :919-924
[3]  
Andreani A, 2000, ANTI-CANCER DRUG DES, V15, P447
[4]  
BABA K, 1981, CHEM PHARM BULL, V29, P2182
[5]   Molecular structure, characterization and stereochemical properties of new biologically interesting 3-(5-imidazo [2,1-b]thiazolylmethylene)-2-indolinones [J].
Giorgi, G ;
Salvini, L ;
Andreani, A ;
Locatelli, A ;
Leoni, A .
JOURNAL OF MOLECULAR STRUCTURE, 2000, 524 :189-199
[6]   IN-VIVO CULTIVATION OF TUMOR-CELLS IN HOLLOW FIBERS [J].
HOLLINGSHEAD, MG ;
ALLEY, MC ;
CAMALIER, RF ;
ABBOTT, BJ ;
MAYO, JG ;
MALSPEIS, L ;
GREVER, MR .
LIFE SCIENCES, 1995, 57 (02) :131-141
[7]   Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5 [J].
Meijer, L ;
Borgne, A ;
Mulner, O ;
Chong, JPJ ;
Blow, JJ ;
Inagaki, N ;
Inagaki, M ;
Delcros, JG ;
Moulinoux, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :527-536
[8]  
Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29
[9]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766
[10]   HETERODIENE SYNTHESES .21. 1-ACETYL-2-OXOINDOLIN-3-YLIDENEACETOPHENONES AND ETHOXYETHYNE - SPIROBICYCLIC INTERMEDIATES IN COMPETITION WITH [2 + 2]-CYCLOADDITIONS AND [4 + 2]-CYCLOADDITIONS [J].
RIGHETTI, P ;
TACCONI, G ;
PICCOLINI, ACC ;
PESENTI, MT ;
DESIMONI, G ;
OBERTI, R .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1979, (04) :863-868